EndoStim, Inc - Medical Equipment - Deals and Alliances Profile

Date: November 4, 2016
Pages: 27
Price:
US$ 250.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: E512CCD72B7EN
Leaflet:

Download PDF Leaflet

EndoStim, Inc - Medical Equipment - Deals and Alliances Profile
Summary

EndoStim, Inc (EndoStim) is a medical device company that develops and commercializes a neurostimulation system for the treatment of severe gastroesophageal reflux disease. The company concentrates on the treatment of gastroesophageal reflux disease through electrical stimulation. It also conducts clinical research for various drugs. EndoStim has also conducted research on common symptoms and causes of gastroesophageal reflux disease. The company has presence in Europe, Asia, and Latin America. It markets its products in domestic and international healthcare markets through its network of distributors. EndoStim is headquartered in Saint Louis, Missouri, the US.

EndoStim, Inc - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope
  • Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
  • Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
  • Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
  • Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
  • Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
  • Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
  • Business Description - A brief description of the company's operations.
  • Key Employees - A list of the key executives of the company.
  • Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
  • Key Competitors - A list of the key competitors of the company.
  • Key Recent Developments - A brief on recent news about the company.
Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements - The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy - The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers. - The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company.
EndoStim, Inc, Medical Equipment, Deals By Year, 2010 to YTD 2016
EndoStim, Inc, Medical Equipment Deals By Type, 2010 to YTD 2016
EndoStim, Inc, Medical Equipment, Deals By Region, 2010 to YTD 2016
EndoStim, Inc, Medical Equipment, Deals By Market, 2010 to YTD 2016
EndoStim, Inc, Medical Equipment, Deals Summary, 2010 to YTD 2016
EndoStim, Inc, Medical Equipment, Deal Details
Venture Financing
EndoStim Raises USD25 Million in Series D Financing
EndoStim Raises USD11 Million in Venture Financing
EndoStim Raises US$14 Million In Venture Financing
EndoStim Secures US$5.6 Million In Series B Venture Financing
EndoStim Secures US$6 Million In Series B Financing Round
Partnerships
EndoStim Enters Into An Agreement With Arizona State University
Equity Offering
EndoStim Withdraws IPO for up to USD38.4 Million
EndoStim, Inc - Key Competitors
Key Employees
Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Corporate Communications
May 17, 2016: EndoStim Names Rohan Hoare, Ph.D., as New President and CEO
Product News
Jul 17, 2015: International Multicenter Trial results of EndoStim LES Stimulation therapy confirm safety and efficacy in patients with GERD
Mar 25, 2015: EndoStim LES Stimulation therapy demonstrates long term safety and efficacy results in treating reflux patients
Mar 11, 2015: EndoStim therapy for reflux receives positive reimbursement decision for 65 hospitals throughout Germany
Clinical Trials
Mar 25, 2015: EndoStim LES Stimulation therapy demonstrates long term safety and efficacy results in treating reflux patients
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

EndoStim, Inc, Medical Equipment, Key Facts
EndoStim, Inc, Medical Equipment, Deals Summary, 2010 to YTD 2016
EndoStim, Inc, Medical Equipment, Deals By Year, 2010 to YTD 2016
EndoStim, Inc, Medical Equipment Deals By Type, 2010 to YTD 2016
EndoStim, Inc, Medical Equipment, Deals By Region, 2010 to YTD 2016
EndoStim, Inc, Deals By Market, 2010 to YTD 2016
EndoStim, Inc, Medical Equipment, Deals Summary, 2010 to YTD 2016
EndoStim Raises USD25 Million in Series D Financing
EndoStim Raises USD11 Million in Venture Financing
EndoStim Raises US$14 Million In Venture Financing
EndoStim Secures US$5.6 Million In Series B Venture Financing
EndoStim Secures US$6 Million In Series B Financing Round
EndoStim Enters Into An Agreement With Arizona State University
EndoStim Withdraws IPO for up to USD38.4 Million
EndoStim, Inc, Key Competitors
EndoStim, Inc, Key Employees
EndoStim, Inc, Other Locations

LIST OF FIGURES

EndoStim, Inc, Medical Equipment, Deals by Type, 2010 to YTD 2016
EndoStim, Inc, Medical Equipment, Deals By Year, 2010 to YTD 2016
EndoStim, Inc, Medical Equipment, Deals By Region, 2010 to YTD 2016
EndoStim, Inc, Medical Equipment, Deals By Market, 2010 to YTD 2016
EndoStim, Inc, Medical Equipment, Deals By Year, 2010 to YTD 2016
EndoStim, Inc, Medical Equipment, Deals by Type, 2010 to YTD 2016
EndoStim, Inc, Medical Equipment, Deals By Region, 2010 to YTD 2016
EndoStim, Inc, Medical Equipment, Deals by Market, 2010 to YTD 2016
Skip to top


Ask Your Question

EndoStim, Inc - Medical Equipment - Deals and Alliances Profile
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: